Apparently
reports of the demise of Green
Mountain Coffee Roasters
(Nasdaq:GMCR)
have been at least a little exaggerated. While the market pioneer for
single-serve coffee brewing has some formidable challenges coming
from increased competition, it's worth remembering that the consumer
products market is not like the prescription drug market where
generic launches immediately drive prices into the cellar. That said,
it's not as though Green Mountain's valuation marks this out as an
especially cheap stock today.
Please read the full article here:
http://www.investopedia.com/
No comments:
Post a Comment